Journal Article DKFZ-2022-02197

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Adherence to a risk-adapted screening strategy for prostate cancer - first results of the PROBASE trial

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023
Wiley-Liss Bognor Regis

International journal of cancer 152(5), 854-864 () [10.1002/ijc.34295]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Note: #EA:C130#LA:C130#LA:C020# / 2023 Mar 1;152(5):854-864

Contributing Institute(s):
  1. Personalisierte Früherkennung des Prostatakarzinoms (C130)
  2. E010 Radiologie (E010)
  3. C060 Biostatistik (C060)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2022
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > E010
Public records
Publication Charges
Publications database

 Record created 2022-09-20, last modified 2024-12-19



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)